106 related articles for article (PubMed ID: 6115653)
1. [Pharmacokinetics of 3H-bamethan in humans].
Hengstmann JH; Steinkamp B
Arzneimittelforschung; 1981; 31(5):843-8. PubMed ID: 6115653
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics and metabolism of 3H-synephrine (author's transl)].
Hengstmann JH; Aulepp H
Arzneimittelforschung; 1978; 28(12):2326-31. PubMed ID: 582950
[TBL] [Abstract][Full Text] [Related]
5. Absolute bioavailability of amezinium. A cross-over study after i.v. and p.o. application.
Kaumeier S; Kehrhahn OH; Morgenthaler H; Neugebauer G
Arzneimittelforschung; 1981; 31(9a):1653-7. PubMed ID: 7197980
[TBL] [Abstract][Full Text] [Related]
6. [Enteral resorption and bioavailability of norfenefrine].
Hengstmann JH; Goronzy J
Arzneimittelforschung; 1980; 30(12):2164-7. PubMed ID: 7194079
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of 3H-phenylephrine in man.
Hengstmann JH; Goronzy J
Eur J Clin Pharmacol; 1982; 21(4):335-41. PubMed ID: 7056280
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
[TBL] [Abstract][Full Text] [Related]
9. Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice.
Sauer JM; Bao J; Smith RL; Kuester RK; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Oct; 25(10):1184-90. PubMed ID: 9321522
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics and bioavailability of the myotonolytic N-(hydroxy-2-ethyl)-cinnamide (author's transl)].
Maier-Lenz H; Ringwelski L; Windorfer A
Arzneimittelforschung; 1980; 30(10):1813-6. PubMed ID: 7192119
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of amezinium in man.
Traut M; Brode E
Arzneimittelforschung; 1981; 31(9a):1605-15. PubMed ID: 7197975
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of the diastereoisomers of leucovorin after intravenous and oral administration to normal subjects.
Straw JA; Szapary D; Wynn WT
Cancer Res; 1984 Jul; 44(7):3114-9. PubMed ID: 6609768
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of a new beta-adrenoceptor blocking agent, LF 17-895, in man.
Gugler R; Kreis L; Dengler HJ
Arzneimittelforschung; 1975 Jul; 25(7):1067-72. PubMed ID: 241357
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of tiapride and absolute bioavailability of three extravascular forms.
Rey E; d'Athis P; Richard MO; de Lauture D; Olive G
Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):62-7. PubMed ID: 7061180
[TBL] [Abstract][Full Text] [Related]
16. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
[TBL] [Abstract][Full Text] [Related]
17. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs.
Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
Res Vet Sci; 2008 Feb; 84(1):85-9. PubMed ID: 17570454
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of difloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications.
Ding HZ; Yang GX; Huang XH; Chen ZL; Zeng ZL
J Vet Pharmacol Ther; 2008 Jun; 31(3):200-4. PubMed ID: 18471140
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and bioavailability of the flavonol quercetin in humans.
Graefe EU; Derendorf H; Veit M
Int J Clin Pharmacol Ther; 1999 May; 37(5):219-33. PubMed ID: 10363620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
